Skip to main content
Figure 2 | Cardiovascular Diabetology

Figure 2

From: Treatment with a copper-selective chelator causes substantive improvement in cardiac function of diabetic rats with left-ventricular impairment

Figure 2

Time- and treatment-dependent changes in blood glucose concentrations, body-weight, and indexes of LV size and composition during the 16-week experimental period in groups of control (n = 12), untreated-diabetic (n = 12) and trientine-treated diabetic (n = 13) adult male rats. Drug treatment was initiated after the measurements of Week 8 (arrowed in A, B). A, Blood glucose concentrations; B, Body-weight; C, Ratio of LV mass to body-weight (LVM/BW); D, Percentage of cardiac fat volume to myocardial volume in the LV. Abbreviation: TETA, triethylenetetramine.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840